Top accelerator startups

14,448 startups · 29 programs

Canos

Active · AI-powered blood test to detect cancer in dogs (and cats soon).

4signal of 100 · rising 4
  • went through YCProgram · this site+4

A sum of public facts, not a judgement and not investment advice.

Competitors

Adjacent

Also from F26 in AI

All of F26

Founders

  • Ming-shan TsaiFounder/CEO

About Canos

Canos is bringing a human-grade liquid biopsy platform for dogs, starting with a single blood draw. We sequence cell-free DNA to perform multi-modal analysis of fragmentation, copy number variation, native methylation (5mC and 5hmC) and more to detect cancer signals. Owners bank a healthy baseline for their dog and track changes every year. Dogs already diagnosed get personalized monitoring through treatment. We partner with mobile vets and vet clinics to serve SF and NYC. Our mission is to make pet cancer curable through early detection and monitoring.

YC batch
F26 · Fall 2026
Status, per YC
Active
Category
AI
Location
Oxford, England, United Kingdom
Founded
2026
Checked
6h ago

YC tags: Anti-Aging, Diagnostics, Biotechnology

Changes seen

Joined a programOct 26, 2026

Joined Y Combinator's Fall 2026 batch (F26).

Canos in F26: 219 companies, 89% AI

LinkedIn

Canos: questions

Which YC batch was Canos in?

Canos was in Y Combinator's Fall 2026 batch (F26).

Is Canos still active?

Y Combinator lists Canos as active.

Who founded Canos?

Canos's founders, as listed on its YC page: Ming-shan Tsai (Founder/CEO).

Where is Canos based?

Canos lists Oxford, England, United Kingdom as its location on YC's directory.